Efficacy and clinical outcome of chemotherapy and endocrine therapy as first-line treatment in patients with hormone receptor-positive HER2-negative metastatic breast cancer

Efficacy and clinical outcome of chemotherapy and endocrine therapy as first-line treatment in patients with hormone receptor-positive HER2-negative metastatic breast cancer

Abstract. Background:. Endocrine therapy (ET) and ET-based regimens are the preferred first-line treatment options for hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (HR+/HER2– MBC), while chemotherapy (CT) is commonly used in cl...

Full description

Bibliographic Details
Main Authors: Yang Yuan, Shaohua Zhang, Tao Wang, Li Bian, Min Yan, Yongmei Yin, Yuhua Song, Yi Wen, Jianbin Li, Zefei Jiang, Rongman Jia, Xiuyuan Hao
Format: Article
Language:English
Published: Wolters Kluwer 2023-06-01
Series:Chinese Medical Journal
Online Access:http://journals.lww.com/10.1097/CM9.0000000000002676

Internet

http://journals.lww.com/10.1097/CM9.0000000000002676

Similar Items